SFDA Extends Regulation Of Ephedrine-Containing Products
This article was originally published in PharmAsia News
Executive Summary
China's State FDA released a notice Feb.21 expressing intentions to further regulate the manufacture and sale of ephedrine-containing pharmaceutical products, while strictly enforcing the law to curb illegal sales
|
China's State FDA released a notice Feb.21 expressing intentions to further regulate the manufacture and sale of ephedrine-containing pharmaceutical products, while strictly enforcing the law to curb illegal sales. Illegal channeling of ephedrine products for the purpose of manufacturing methamphetamine has become a prominent issue in China's fight against drugs. The notice calls on manufacturers, regulatory departments, and others to focus on tracking the distribution and sale of these products to prevent loss. It also calls on all areas to actively organize a variety of advocacy, training, and warning initiatives and raise awareness of ephedrine abuse while encouraging corporate social responsibility. (Click Here For More - Chinese Language) "SFDA Will Punish Illegal Sale Of Ephedrine-Containing Preparations"- health.sohu.com (2.21.10) |